MISurf Versus InSurE. A Comparison of Minimally Invasive Surfactant Application Techniques in Preterm Infants

NCT01615016 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Delay due to infrastructural reasons. Funding withdrawn

Conditions

Hyaline Membrane Disease

Interventions

OTHER: Minimally invasive endotracheal surfactant application

Sponsor

Hamilton Health Sciences Corporation